Labileno

Lamotrigine, the active ingredient in Labileno, is an anticonvulsant presented as an oral tablet for oral use. It is employed to control partial seizures, generalized tonic‑clonic seizures, and to provide maintenance therapy for bipolar disorder in adult patients. The medication is formulated to ensure consistent absorption and bioavailability.

GNH USA supplies Labileno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our global distribution network ensures reliable delivery and regulatory compliance across multiple regions.

Lamotrigine is used to manage seizure disorders and bipolar disorder, acting on neuronal excitability.

Partial seizures: reduces frequency and severity of focal onset seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with generalized epilepsy. Bipolar disorder (maintenance therapy): stabilizes mood and decreases recurrence of depressive and manic episodes.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea or vomiting - Blurred vision - Skin rash - Insomnia

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions with blistering or peeling - Blood dyscrasias such as agranulocytosis or aplastic anemia - Hepatic failure - Anaphylactic reaction - Multiorgan hypersensitivity

When prescribing lamotrigine, clinicians should observe several precautionary measures to minimize risks.

Dose titration: start low and increase gradually to reduce the risk of skin rash. Skin monitoring: inspect regularly for any rash or hypersensitivity signs. Renal impairment: adjust therapy if significant renal dysfunction is present. Hepatic impairment: use with caution and monitor liver function. Pregnancy: limited data; benefits must outweigh potential risks. Store at ambient temperature: keep in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase adverse effect risk.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, requiring dose reduction. - Carbamazepine: reduces lamotrigine concentrations, potentially diminishing efficacy. - Phenobarbital: lowers lamotrigine levels, may necessitate dose adjustment. - Phenytoin: decreases lamotrigine exposure, affecting seizure control.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine levels, monitor seizure frequency. - Serotonergic agents: possible increased risk of serotonin syndrome, observe for symptoms.